Form 8-K - Current report:
SEC Accession No. 0000950123-09-022058
Filing Date
2009-07-14
Accepted
2009-07-14 10:53:52
Documents
2
Period of Report
2009-07-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y01922e8vk.htm 8-K 9336
2 EX-99.1 y01922exv99w1.htm EX-99.1 7143
  Complete submission text file 0000950123-09-022058.txt   18219
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 09943152
SIC: 2836 Biological Products, (No Diagnostic Substances)